Neurogene Inc. (NGNE)
NASDAQ: NGNE · Real-Time Price · USD
25.83
+2.36 (10.06%)
At close: Oct 8, 2025, 4:00 PM EDT
25.50
-0.33 (-1.28%)
After-hours: Oct 8, 2025, 7:57 PM EDT

Neurogene Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21
369340249--
Market Cap Growth
-30.38%36.64%---
Enterprise Value
105214452--
Last Close Price
25.8322.8619.38--
PE Ratio
--18.20--
PS Ratio
-367.11---
PB Ratio
1.351.091.34--
P/TBV Ratio
1.351.091.34--
EV/Sales Ratio
-231.03---
Debt / Equity Ratio
0.040.040.080.050.06
Asset Turnover
-0.00---
Quick Ratio
17.8620.658.6112.486.57
Current Ratio
18.0720.848.7212.746.81
Return on Equity (ROE)
-39.41%-30.28%-25.52%-59.77%-
Return on Assets (ROA)
-25.07%-18.47%-20.94%-33.52%-
Return on Capital (ROIC)
-26.40%-19.69%-22.83%-36.31%-
Earnings Yield
-22.89%-22.13%-14.61%--
FCF Yield
-20.21%-21.03%-20.82%--
Buyback Yield / Dilution
-52.10%-277.22%-1080.37%90.26%-
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q